Latest news for BWX Technologies (NYSE:BWXT) Stock

BWX Technologies

BWX Technologies Inc is a specialty manufacturer & service provider of nuclear components. It operates in two segments. The government Operations segment consists of legacy Nuclear Operations Group & Nuclear Services Group segments with certain research & development activities in the areas of advanced reactors & advanced manufacturing. The commercial Operations segment consists of the legacy Nuclear Power Group segment with certain research and development & commercialization activities in the areas of medical & industrial radioisotopes & radiopharmaceuticals. The majority is from the Government Operations segment. Geographically, it operates in the United States, Canada & United Kingdom, out of which the majority is from the United States.

Earnings

News

Penny Stocks

Markets

Analyst Ratings

Tech

Trading Ideas

BWXT

FTNT

INTC

Intel Corporation (NASDAQ: INTC) is scheduled to report second-quarter 2024 results on Aug 1, after the closing bell. In the to-be-reported quarter, the company is likely to have recorded higher revenues year over year from the Client Computing Group, backed by a strong emphasis on product innovation.

Can Healthy Processor Revenues Aid Intel&#39;s Q2 Earnings?

Options

Investors in BWX Technologies, Inc. (NYSE: BWXT) need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 16, 2024 $60.00 Put had some of the highest implied volatility of all equity options today.

Is the Options Market Predicting a Spike in BWX Technologies Stock?

Blackberry_logo_desert

Long Ideas

Media

ASTS

Jim Cramer is not going to recommend Schlumberger, as it has &#34;got too much business that is not acting well right now.&#34; And BlackBerry? &#34;No.&#34;

Jim Cramer Isn&#39;t Recommending SLB, And BlackBerry? &#39;Nothing There&#39;

BWX Technologies Inc

BWX Technologies Secures NNSA Contract For Engineering Study On Domestic Uranium Enrichment Centrifuge Pilot Plant, Advancing National Security Capabilities In Partnership With ORNL And Fluor

Deutsche Bank analyst Scott Deuschle maintains BWX Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) with a Buy and raises the price target from $112 to $113.

Price Target

Deutsche Bank Maintains Buy on BWX Technologies, Raises Price Target to $113

Guidance

BWX Technologies Narrows 2024 Adj EPS Guidance From $3.05-$3.20 To $3.10-$3.20, Est $3.17

WIIM

BWX Technologies shares are trading higher after the company reported better-than-expected Q2 financial results.

BWX Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) reported quarterly earnings of $0.82 per share which beat the analyst consensus estimate of $0.75 by 9.33 percent. The company reported quarterly sales of $681.465 million which beat the analyst consensus estimate of $639.313 million by 6.59 percent. This is a 11.27 percent increase over sales of $612.445 million the same period last year.

Earnings Beats

BWX Technologies Q2 2024 Adj. EPS $0.82 Beats $0.75 Estimate, Sales $681.465M Beat $639.313M Estimate

BWX Technologies's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) short percent of float has fallen 7.86% since its last report. The company recently reported that it has 1.05 million shares sold short, which is 1.29% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.85 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>BWX Technologies Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722533423_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for BWX Technologies has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing BWX Technologies's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, BWX Technologies's peer group average for short interest as a percentage of float is 2.36%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into BWX Technologies's Recent Short Interest

Intel Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intc#NASDAQ">INTC</a>) is scheduled to report second-quarter 2024 results on Aug 1, after the closing bell. In the to-be-reported quarter, the company is likely to have recorded higher revenues year over year from the Client Computing Group, backed by a strong emphasis on product innovation. Efforts to increase efficiency in semiconductor manufacturing and improve the supply chain are positive factors.
<h3>Factors at Play</h3>
CCG is the company&#39;s largest segment and accounts for the lion&#39;s share of total revenues. It includes computer CPUs, several server boards, form factor systems and graphic products.
During the second quarter, Intel announced that it has surpassed 500 AI models optimized for the Intel core Ultra processors. The models cover a wide array of AI applications including large language models, diffusion, super resolution, object detection and computer vision. These AI applications can be deployed across various processing units within the Ultra Core processors, including CPU, GPU and NPU (Neural Processing Unit). This has significantly bolstered Intel&#39;s position in the emerging market of AI PCs.
Intel is steadily advancing towards its target of shipping more than 40 million AI PC processors in 2024. The company is scaling its AI footprint to edge devices and PCs with its Core Ultra processors, supporting more than 100 software vendors.
In the quarter under review, Intel unveiled the Lunar Lake architecture at Computex 2024. The Lunar Lake processors will bolster the capabilities of Neural Processing Units and deliver significant performance improvement in AI PCs. Featuring advanced graphics and AI processing power, the solution promises improvements across the security, battery life and power efficiency of devices. These developments are likely to have boosted revenues from this segment.
<h3>Overall Expectations</h3>
The Zacks Consensus Estimate for revenues from the CCG segment is pegged at $7.51 billion, indicating an increase from $6.78 billion in the year-ago quarter. Our estimate for revenues from this segment is pegged at $7.43 billion, suggesting 9.7% growth year over year.
For the June quarter, the Zacks Consensus Estimate for total revenues is pegged at $12.92 billion, which indicates a decrease from the year-ago quarter&#39;s reported figure of $12.95 billion. The consensus estimate for adjusted earnings per share stands at 10 cents, suggesting a decline from 13 cents reported in the prior year.
<h3>Earnings Whispers</h3>
Our proven model does not conclusively predict an earnings beat for Intel for the second quarter. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. This is not the case here. 
Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, is +10.79%. The Most Accurate Estimate is pegged at 11 cents, while the Zacks Consensus Estimate stands at 10 cents.
<div class="chart_embed">
<h3>Intel Corporation Price and EPS Surprise</h3>
<img alt="Intel Corporation Price and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/89/1722438714.png" style="height:263px; width:538px" title="" />
Intel Corporation price-eps-surprise | Intel Corporation Quote
</div>
Zacks Rank: Intel has a Zacks Rank #4 (Sell).
<h3>Stocks to Consider</h3>
Here are some companies you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this season:
Fortinet (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ftnt#NASDAQ">FTNT</a>) is set to release quarterly numbers on Aug 6. It has an Earnings ESP of +3.41% and a Zacks Rank #3.
The Earnings ESP for BWX Technologies (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bwxt#NYSE">BWXT</a>) is +0.88% and it carries a Zacks Rank of 3. The company is scheduled to report quarterly numbers on Aug 5.
The Earnings ESP for Watts Water Technologies (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wts#NYSE">WTS</a>) is +1.17% and it carries a Zacks Rank of 3. The company is scheduled to report quarterly numbers on Aug 7.
<a href="https://www.zacks.com/stock/news/2313381/can-healthy-processor-revenues-aid-intel-s-intc-q2-earnings?cid=CS-BENZ-FT-analyst_blog|earnings_preview-2313381">To read this article on Zacks.com click here.</a>

Can Healthy Processor Revenues Aid Intel's Q2 Earnings?

Barclays analyst David Strauss downgrades BWX Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) from Equal-Weight to Underweight and raises the price target from $75 to $90.

Downgrades

Barclays Downgrades BWX Technologies to Underweight, Raises Price Target to $90

Actinium-225 (Ac-225) is&nbsp;a critical medical isotope used to kill cancer cells while minimizing the impact to healthy tissues.

Contracts

NorthStar Medical Radioisotopes, BWXT Medical Sign Multi-Year Master Services Agreement, Which Will Facilitate The Production Of Ac-225

BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) and NorthStar Medical Radioisotopes, LLC (NorthStar) today announced that they have signed a Master Services Agreement (MSA), which will facilitate the production of actinium-225 (Ac-225), a critical medical isotope used to kill cancer cells while minimizing the impact to healthy tissues.
Medical isotopes are essential for a wide range of diagnostic and therapeutic procedures, including cancer treatments and advanced imaging techniques. Pursuant to the multi-year MSA, the companies will work together to process and purify radium-226. The scope of the agreement also includes potential target design projects and exploration of opportunities to provide backup supply to each other&#39;s customers.

BWXT Medical and NorthStar Partner to Produce Cancer-Fighting Isotope Ac-225

BWX Technologies's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) short percent of float has risen 14.29% since its last report. The company recently reported that it has 977 thousand shares sold short, which is 1.2% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.12 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>BWX Technologies Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720110610_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for BWX Technologies has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing BWX Technologies's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, BWX Technologies's peer group average for short interest as a percentage of float is 2.58%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into BWX Technologies's Recent Short Interest

Investors in BWX Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bwxt#NYSE">BWXT</a>) need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 16, 2024 $60.00 Put had some of the highest implied volatility of all equity options today.
<h3>What is Implied Volatility?</h3>
Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
<h3>What do the Analysts Think?</h3>
Clearly, options traders are pricing in a big move for BWX Technologies shares, but what is the fundamental picture for the company? Currently, BWX Technologies is a Zacks Rank #3 (Hold) in the Electronics - Miscellaneous Components industry that ranks in the Bottom 18% of our Zacks Industry Rank. Over the last 60 days, two analysts have increased their earnings estimates for the current quarter, while none have dropped their estimates. The net effect has taken our Zacks Consensus Estimate for the current quarter from earnings of 73 cents per share to 74 cents in that period. 
Given the way analysts feel about BWX Technologies right now, this huge implied volatility could mean there&#39;s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
<a href="https://www.zacks.com/stock/news/2296158/is-the-options-market-predicting-a-spike-in-bwx-technologies-bwxt-stock?cid=CS-BENZ-FT-tale_of_the_tape|options-2296158">To read this article on Zacks.com click here.</a>

Janney Montgomery Scott analyst Thomas Meric initiates coverage on BWX Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) with a Buy rating and announces Price Target of $113.

Initiation

Janney Montgomery Scott Initiates Coverage On BWX Technologies with Buy Rating, Announces Price Target of $113

BTIG analyst Andre Madrid initiates coverage on BWX Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) with a Buy rating and announces Price Target of $110.

BTIG Initiates Coverage On BWX Technologies with Buy Rating, Announces Price Target of $110

Support Strong Among Wyoming Stakeholders and Potential Vendors During Phase One of Cost-Share Program

BWX Technologies Awarded Phase Two Microreactor Evaluation Contract For State of Wyoming; $20M Total Value Of Cost-Share Program And Phase Two Expected Completion By Q3 2025

BWX Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) today announced a contract award from the U.S. Department of Energy, National Nuclear Security Administration (DOE/NNSA) for management and operations of the Pantex Plant. Following an initial term of five years, NNSA has the ability to award three additional five-year option periods. If all contract options are exercised, the contract will span 20 years at a funding level of approximately $30 billion.
The NNSA announced the contract was awarded to PanTeXas Deterrence LLC (PXD). PXD is a joint venture led by a BWX Technologies, Inc. (BWXT) subsidiary &ndash; it also includes Fluor; SOC, A Day &amp; Zimmermann Company; and The Texas A&amp;M University System.

BWXT-led Team Inks Up To 20-Year, $30B Management And Operating Contract For National Nuclear Security Administration's Pantex Plant

Deutsche Bank analyst Scott Deuschle maintains BWX Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) with a Buy and lowers the price target from $110 to $107.

Deutsche Bank Maintains Buy on BWX Technologies, Lowers Price Target to $107

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer said he is not going to recommend Schlumberger Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) here, even though he likes the company as it has &#8220;got too much business that is not acting <a href="https://www.benzinga.com/quote/SLB/earnings">well right now.</a>&#8220;
On April 19, Schlumberger reported upbeat sales for its first quarter.
When asked about BWX Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>), he said, &#8220;Interesting, but I'm going to have to give you GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>). I need to have some stability, yours does not have the stability that I like.&#8221;
On May 6, BWX Technologies posted better-than-expected first-quarter earnings. The company posted adjusted earnings of 76 cents per share, beating market estimates of 69 cents per share. The company's quarterly sales came in at $603.933 million topping expectations of $599.914 million.
The &#8220;Mad Money&#8221; host said AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) has had &#8220;too big a move.&#8221;
On May 29, AST SpaceMobile announced a partnership with Verizon Communications Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) to provide Verizon customers with direct-to-cellular AST SpaceMobile <a href="https://www.benzinga.com/news/24/05/39062478/whats-going-on-with-ast-spacemobile-stock-on-wednesday">service when needed</a>.
When asked about BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>), Cramer said, &#8220;No, nothing there.&#8221;
On April 9, BlackBerry announced a collaboration with Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), designed to revolutionize next-generation robotic systems by enabling new levels of low latency and jitter, as well <a href="https://www.benzinga.com/markets/equities/24/04/38159493/why-is-blackberry-stock-rising-today">as repeatable determinism.</a>
Price Action:
<ul>
<li>SLB shares rose 2% to settle at $44.55 on Friday.</li>
<li>BlackBerry shares fell 4.6% to close at $2.68 on Friday.</li>
<li>AST SpaceMobile fell 7.5% to close at $8.62 during Friday's session.</li>
<li>BWX Technologies shares fell 0.3% to close at $89.45.</li>
</ul>
Read Next: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/06/39226661/top-4-tech-stocks-that-may-explode-this-month">Top 4 Tech Stocks That May Explode This Month</a>
Image: Vanva

Jim Cramer Isn't Recommending SLB, And BlackBerry? 'Nothing There'

BWXT Medical Ltd. has submitted a Drug Master File (DMF) to the U.S. Drug and Food Administration (FDA) for No Carrier Added (n.c.a.) Actinium-225 (Ac-225) Active Pharmaceutical Ingredient.
Ac-225 is an alpha-emitting isotope used in targeted alpha therapies (TATs) that combine the isotope with specific tumor-seeking targeting vectors to kill cancer cells while minimizing the impact to healthy tissues.

BWX Technologies Submits Drug Master File To US Food And Drug Administration For No Carrier Added Actinium-225 Active Pharmaceutical Ingredient

CLSA analyst Max Hopkins initiates coverage on BWX Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) with a Buy rating.

CLSA Initiates Coverage On BWX Technologies with Buy Rating

Barclays analyst David E. Strauss maintained a Sell rating on BWX Technologies (BWXT – Research Report) today and set a price target of $90.00. The...

BWX Technologies (BWXT) Gets a Sell from Barclays

Franklin Small Cap Growth Fund Q2 2024 Commentary

Nuclear energy has become one of the hottest industries on Wall Street over the last year as investors realize its ability to power the growing global economy as the world attempts to curb fossil fuel use.

3 Nuclear Energy Stocks To Buy And Hold Forever

BWX bags Nuclear Security Administration contract

Is it time to make portfolio changes before the 2024 U.S. election?

Dividend Champion, Contender, And Challenger Highlights: Week Of September 1

35 "green" energy stocks for a new era of profitability - Citi

BWX Technologies Trending Upward On Profitable Growth

Cameco: Nuclear Industry Excitement Provides More Fuel, Services, And New Design Opportunities

These are the mid-caps that could perform best during 'downturn' regimes – BofA

ACGL

AKAM

AMBP

AMCR

AMGN

AMSF

ARIS

BALL

BLOK

BOTJ

BRBR

CBOE

CBSH

CCBG

CCOI

CHRW

CINF

CLSK

CNOB

COIN

COPX

CTAS

DGRO

EBMT

EBTC

ERII

EXPO

EYPT

FELE

FERG

FRME

FRPT

GBTC

GLCNF

GLNCY

GOLF

GUSH

HIVE

HOMB

HTLD

IBKR

ICLN

INGR

INSM

INSP

ITGR

JKHY

KLAC

LANC

LBRT

LDOS

LFUS

LRCX

LSCC

MAIN

MARA

MATX

MBWM

MCHP

MKTX

MNDY

MSEX

MSTR

MTRN

MUSA

NRIM

ODFL

OLLI

ONTO

OTIS

PAAS

PATK

PESI

PHYS

PPLL

PSLV

QCLN

QCOM

RIOT

ROST

RYCEY

SBSI

SCCO

SEDG

SHLS

SIGI

SOJC

SPHD

SPLV

SRCL

TCBK

TECK

TSLA

TXRH

UNTY

USOI

VALE

VLTO

WAFD

WING

WSBC

WTRG

Press Releases

BWX Technologies Reports First Quarter 2024 Results

BWXT Medical Submits Drug Master File for Actinium-225 API to U.S. Food and Drug Administration

BWXT-led Team Awarded $30 Billion Management and Operating Contract for National Nuclear Security Administration's Pantex Plant

BWXT Awarded Phase Two of Microreactor Evaluation Contract for State of Wyoming

BWX Technologies to Announce Second Quarter 2024 Results on Monday, August 5

BWXT Medical and NorthStar Medical Radioisotopes Sign Supply Agreement Supporting Actinium-225 Production

NorthStar Medical Radioisotopes and BWXT Medical Sign Supply Agreement Supporting Actinium-225 Production

BWX Technologies Reports Second Quarter 2024 Results

BWXT Names Vittorio Puppo President of Medical Business

BWXT Awarded Contract to Develop Pilot Plant Solution for Domestic Uranium Enrichment

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

BWX Technologies

News

Latest news for BWX Technologies (NYSE:BWXT) Stock

People Also Watch